Suppressing protein damage response to overcome multidrug resistance in cancer therapy
Fangyuan Shao(University of Macau), Chu‐Xia Deng(Tongji University), Bo Li(Northwestern Polytechnical University), Yuheng Zhang(University of Electronic Science and Technology of China), Yuzhong Peng(Fifth Affiliated Hospital of Zhengzhou University), Xingsi Han(Guangdong Academy of Agricultural Sciences), Hao Xiao(Shanghai Academy of Social Sciences), Jiaxin Yao(Fujian Medical University), Yanxia Shi(Chinese Academy of Agricultural Sciences), Kai Miao(University of Macau), Xiangpeng Chu(University of Macau), Xinyi Li(Harvard University), Haifeng Li(University of Macau), Lei Li(Jiangnan University), Ying Lin(Shanghai Jiao Tong University), Zongjie Li(University of Macau), Yujun Chen(Jilin University of Finance and Economics), Lijian Wang(Massachusetts General Hospital), Dongyang Tang(University of Macau), Maoxin Ran(University of Macau), Cuiting Zhang(Jilin University), Jun Yan(Fujian Medical University), Xiaoling Xu(Nanjing Normal University)
Cited by 4
Related Papers
Substrate and Functional Diversity of Lysine Acetylation Revealed by a Proteomics Survey
|Molecular Cell|2006|1.5k
Murine FGFR-1 is required for early postimplantation growth and axial organization.
|Genes & Development|1994|748
Genomic instability in Gadd45a-deficient mice
|Nature Genetics|1999|517
Tumor heterogeneity reshapes the tumor microenvironment to influence drug resistance
|International Journal of Biological Sciences|2022|350